HPMC

Intoleran Prioritizes a Clean Digestive Enzyme Manufacturing Process

Retrieved on: 
Thursday, November 30, 2023
Enzyme, Starch, Digestion, HPMC, Research, Stomach, American Gastroenterological Association, Bloating, Fructose, Food intolerance, Crohn's disease, Calcium carbonate, Lactase, Nausea, Lactose, Extrapyramidal system, Animal feed, Dairy

FORT LAUDERDALE, Fla., Nov. 30, 2023 /PRNewswire/ -- There are many reasons an individual might struggle with digestive concerns. In 2022, the American Gastroenterological Association (AGA) reported new research revealing that as much as 40% of Americans suffer from "digestive troubles" on a daily basis. At times, this can be severe and can stem from serious medical concerns, such as celiac disease or Crohn's disease.

Key Points: 
  • "Food intolerance is typically a lack of digestive enzymes in the body," explains Harmen Treep, owner of Intoleran.
  • However, to be effective, enzymes must be clean and should not contain ingredients that complicate digestive issues.
  • "If a digestive enzyme comes with a lengthy ingredients list on the bottle, think twice," Treep warns.
  • The Intoleran owner uses his brand's lactase 10,000 digestive enzyme capsules as an example.

Intoleran Offers a Clean and Uncomplicated Solution to a Lactose Intolerance

Retrieved on: 
Friday, August 4, 2023
Lactase, HPMC, Human, Food, Lactose intolerance, Diet, Food intolerance, Enzyme, Tablet, Capsule, Gold, OTC, Calcium carbonate, Animal feed, Dairy, Pharmaceutical industry

FORT LAUDERDALE, Fla., Aug. 4, 2023 /PRNewswire/ -- Digestive enzymes are an organic way that humans break down and digest their food. When a person cannot create enough of these enzymes for a certain food group, they can develop a food intolerance. One of the most common of these digestive shortcomings is a lack of the dairy-related enzyme lactose. It's estimated that at least a third of the world's population (and possibly twice that number) suffer from some degree of lactose intolerance.

Key Points: 
  • It's estimated that at least a third of the world's population (and possibly twice that number) suffer from some degree of lactose intolerance.
  • A solution for lactose intolerance is to cut foods with lactose out of one's diet.
  • Along with a clean production process, Intoleran considers the diverse set of circumstances within which individuals across the globe must manage lactose intolerance.
  • But only Intoleran is providing an enzyme supplement for lactose that is worth its weight in gold.

Intoleran Is Helping People Live With IBS

Retrieved on: 
Tuesday, May 2, 2023
Lactase, Extrapyramidal system, HPMC, Mayo Clinic, Food, Irritable bowel syndrome, Gastrointestinal tract, Digestion, FODMAP, Stomach, Defecation, IBS, Diagnosis, HACCP, Calcium carbonate, Animal feed

FORT LAUDERDALE, Fla., May 2, 2023 /PRNewswire/ -- Irritable bowel syndrome or IBS is a common condition that encompasses a range of dietary concerns. Mayo Clinic defines IBS as "a common disorder that affects the stomach and intestines, also called the gastrointestinal tract."

Key Points: 
  • Mayo Clinic defines IBS as "a common disorder that affects the stomach and intestines, also called the gastrointestinal tract."
  • The medical site adds that IBS is currently diagnosed using the Rome IV criteria (a formal set of diagnosis guidelines).
  • While IBS is common and involves digestional discomfort, it remains an umbrella term with many symptoms and definitions.
  • "We aren't just helping people with their digestion," Treep declares, "We're enabling them to enjoy life again."

Merck & XtalPi Collaboration Optimizes Drug Formulations with AI-Powered Techniques

Retrieved on: 
Friday, April 14, 2023
Science, HPMC, Drug development, Crystallization, Therapy, Hydrogen chloride, Metformin, Engineering, Artificial intelligence, Merck, Micronization, Automation, Medical imaging, Pharmaceutical industry

SHENZHEN, China and DARMSTADT, Germany, April 14, 2023 /PRNewswire/ -- Science and technology company Merck and XtalPi Inc., a pioneering pharmaceutical technology company powered by artificial intelligence (AI) and automation, have jointly published a study that highlights the benefits of combining computational workflows with wet lab experiments to advance drug development.

Key Points: 
  • Traditional methods like milling and micronization, used to address undesirable crystal morphologies, can be disruptive and costly.
  • The collaboration between Merck and XtalPi focused on the impact of different polymer additives on the crystal habit of metformin HCl, a diabetes medication.
  • Dr. Jan Gerit Brandenburg, Head of Digital Chemistry at Merck, added, "Our collaboration with XtalPi is transforming pharmaceutical development.
  • By seamlessly incorporating computer simulations with our experimental formulation expertise in a 'digital-first' approach, we are boosting drug development processes and positively impacting patients' lives."

Nutraceutical Contract Manufacturing Services Global Market Report 2023: Expanding Healthcare Infrastructure and Demand for Personalized Nutrition Fuels Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, April 3, 2023
Pharmaceutical, Health, Fitness & Nutrition, HPMC, Food, Gencor, Drink, Prevalence, Nature's Sunshine Products, Lonza, Functional food, Research, USD, DSM (company), Tablet, Capsule, Patent, Dietary supplement, Economic development, Conditional sentence, Region, Probiotic, Pharmaceutical industry

The "Nutraceutical Contract Manufacturing Services Market By Dosage Form, By Product, and by Region - Global Forecast to 2023-2033" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Nutraceutical Contract Manufacturing Services Market By Dosage Form, By Product, and by Region - Global Forecast to 2023-2033" report has been added to ResearchAndMarkets.com's offering.
  • The nutraceutical contract manufacturing services market size is estimated to be USD 114.2 billion in 2022 and is expected to witness a CAGR of 12.01% during the forecast period 2023-2033.
  • Increasing health consciousness, growing need for personalized nutrition, increasing use of modern technology and expanding healthcare infrastructure are projected to drive the market growth in near future.
  • The expansion of the healthcare infrastructure and increased use of contemporary technology are anticipated to drive market growth throughout the anticipated timeframe.

Hollywood Presbyterian Medical Center & Sentara Healthcare implement clinical quality improvement solution from Wolters Kluwer

Retrieved on: 
Thursday, March 9, 2023
Technology, Managed Care, Hospitals, Science, Nursing, Clinical Trials, Health, Other Science, Other Education, Research, Continuing, Training, Software, Networks, Education, Practice Management, Artificial Intelligence, Magnet, Wolters Kluwer, New York State Education Department, Learning, MSLS, Student, Pressure, Governance, Institute of Museum and Library Services, Patient, Multimedia, Artificial intelligence, Hospital, University, Caregiver, UAB, Organization, Birmingham School of Law, HPMC, Senior, Sentara Healthcare

Hollywood Presbyterian Medical Center (HPMC) and Norfolk, VA-based Sentara Healthcare are implementing Wolters Kluwer Health’s Ovid® Synthesis Clinical Evidence Manager solution, to support evidence-based clinical research initiatives.

Key Points: 
  • Hollywood Presbyterian Medical Center (HPMC) and Norfolk, VA-based Sentara Healthcare are implementing Wolters Kluwer Health’s Ovid® Synthesis Clinical Evidence Manager solution, to support evidence-based clinical research initiatives.
  • “Sentara has used Ovid for years to help our clinicians with research,” said Suzanne Duncan, MSLS, Director of Library Services for Sentara Healthcare.
  • “We have now added Ovid Synthesis Clinical Evidence Manager to assist with all our clinical research and tracking, as well as compliance for Magnet recognition and renewal.
  • The division of Wolters Kluwer supports clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions.

Vivion, Inc. Launches New Empty Capsules Product Range

Retrieved on: 
Thursday, February 2, 2023
Capsule, Pharmacy, Medicine, CGMP, Gelatin, Food, Vitamin, HPMC, Mineral, Vivion, Dicarboxylic acid, Dietary supplement

Along with providing ingredients for the nutraceutical, pharmacy, food, beverage and other consumable industries, Vivion is expanding its product selection and launching a full line of empty capsules.

Key Points: 
  • Along with providing ingredients for the nutraceutical, pharmacy, food, beverage and other consumable industries, Vivion is expanding its product selection and launching a full line of empty capsules.
  • Vivion's two-piece capsules are ideal for encapsulating powder and herbs and can be used for medicines, vitamins, supplements, herbal products, amino acids and more.
  • There is an option for nearly every preference with Vivion's capsule range, including gelatin capsules derived from natural bovine sources, as well as the plant-based HPMC capsules and pullulan capsules.
  • "Operio Group's expertise in equipment, formulation and ingredients uniquely positions us to be a natural resource and supplier of capsules.

Empty Capsules Market is expected to generate a revenue of USD 4.64 Billion by 2030, Globally, at 7.00% CAGR: Verified Market Research®

Retrieved on: 
Wednesday, February 1, 2023
Capsule, Antacid, Cancer, Geography, ACG Group, Gelatin, Research, Starch, USD, HPMC, Growth, Infection, Retail, Dietary supplement, Fine chemical, Application

JERSEY CITY, N.J., Feb. 1, 2023 /PRNewswire/ -- Verified Market Research® recently published a report, "Empty Capsules Market" By Type (Gelatine Capsules, Non-gelatine Capsules), By Functionality (Immediate-Release Capsules, Sustained-Release Capsules), By Application (Antacid & Antiflatulent Preparations, Antianemic Preparations), By End-User (Nutraceutical Industry, Pharmaceutical Industry), and By Geography.

Key Points: 
  • As per the deep research carried out by Verified Market Research®, the global Empty Capsules Market size was valued at USD 2.52 Billion in 2021 and is projected to reach USD 4.64 Billion by 2030, growing at a CAGR of 7.00% from 2023 to 2030.
  • Verified Market Research® narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study.
  • The "Global Empty Capsules Market" is mainly bifurcated into sub-segments which can provide classified data regarding the latest trends in the market.
  • The "Global Empty Capsules Market" study report will provide valuable insight with an emphasis on the global market.

Empty Gelatin Capsule Market Report 2022-2028: Increasing Prevalence of Chronic Diseases Fuels 8.1% Annual Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 15, 2022
Chemicals, Plastics, Pharmaceutical, Health, Manufacturing, Lyfe, Wickham Laboratories Ltd, Penicillamine, Capsule, Cystinuria, Food industry, Wilson's disease, ACG Group, Prevalence, Degenerative disease, Cancer, Gelatin, Conditional sentence, Diabetes, HPMC, CVD, Growth, Wilson, USFDA, Dietary supplement, Fine chemical

The global empty gelatin capsule market is anticipated to grow at a significant CAGR around 8.1% during the forecast period (2022-2028).

Key Points: 
  • The global empty gelatin capsule market is anticipated to grow at a significant CAGR around 8.1% during the forecast period (2022-2028).
  • The major factor for the growth of the market is the increasing prevalence of chronic diseases such as CVD, cancer, diabetes, and gastrointestinal diseases coupled with the rising demand for gelatin capsules.
  • The global empty gelatin capsule market is segmented based on the type and based on end-user.
  • Also, the rise in prevalence of chronic diseases such as cardiovascular diseases and cancer, and advancement in capsule drug delivery technology in the region are some of the factors that are driving the global empty gelatin capsule market.

Global Softgel Capsule Market Report 2022: Increased Number of Clinical Trials Supporting Softgel Capsule Use to Drive Revenue Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 15, 2022
Health, Pharmaceutical, APIS, Taste, CCRT, Trial of the century, HPMC, Starch, Absorption, Analysis, IP, MEA, Patent, Patient, Projection, Manufacturing, USD, Safety, Application, Softgel, Intellectual property, Stomach, Capsule, Pregnancy, Organization, Risk, BTC, Pharmaceutical industry

The "Global Softgel Capsule Market, By Type, By Application, By Manufacturers & By Region- Forecast and Analysis 2022-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Softgel Capsule Market, By Type, By Application, By Manufacturers & By Region- Forecast and Analysis 2022-2028" report has been added to ResearchAndMarkets.com's offering.
  • Softgel capsules have several advantages, including ease of ingesting, odour and taste masking, improved absorption, higher bioavailability, and superior atmospheric stability.
  • Global Softgel capsule market is segmented based on type, application, manufacturers, and region:
    Based on type, market is segmented into gelatin/animal based, non animal.
  • The increasing number of clinical trials testing the efficacy of soft gelatin capsules in the treatment of various disorders is a significant factor fueling market expansion.